Type
- ARTG (99)
- Cancellation by sponsor (27)
- Prescription medicine registration (19)
- Australian public assessment report (AusPar) (13)
- Prescription medicine evaluation (3)
- Section 14, TGO91 consent (3)
- Designation or determination (2)
- Prescription medicine decision summary (2)
- Cancellation or suspension (1)
Sponsor content
169 result(s) found, displaying 21 to 30
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RYALTRIS olopatadine 600 microgram/actuation and mometasone furoate 25 microgram/actuation nasal spray bottle.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
Sep-2025Prescription medicine evaluationActive ingredient: Influenza virus haemagglutinin.
-
Sep-2025Prescription medicine evaluationActive ingredient: Bempedoic acid, ezetimibe.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
Prescription medicine registrationActive ingredients: Influenza virus haemagglutinin.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Bulk Influenza Vaccine (Split virion, inactivated) Thiomersal-free.
-
Australian public assessment report (AusPar)Onakta (tirbanibulin) was approved for the topical field treatment of actinic keratosis of the face or scalp in adults.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Panvax H5N8 pre-pandemic, Pre-pandemic influenza vaccine (split-virion, inactivated) 10 mL multi-dose injection vial.